Status:
COMPLETED
Synergistic Effect of Vitamin D Supplementation in Patients With Vitiligo and Vitamin D Deficiency
Lead Sponsor:
Hallym University Kangnam Sacred Heart Hospital
Conditions:
Vitamin D Deficiency
Vitiligo
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This prospective, randomized, controlled study was approved by the Institutional Review Board of Hallym University Kangnam Sacred Heart Hospital (IRB no. 2018-04-017). All study participants consented...
Eligibility Criteria
Inclusion
- patients diagnosed with non-segmental vitiligo based on clinical diagnosis.
- patients who were ≥ 18 years old.
- patients with lower serum vitamin D level (\<20ng/mL).
Exclusion
- patients taking medicines such as thiazide, diuretics, lithium which can influence the serum vitamin D level.
- pregnant or lactating women.
- patients with diseases which can affect kidney such as chronic kidney disease, hyperparathyroidism, or hypoparathyroidism.
- patients with uncontrolled chronic diseases like diabetes mellitus, hyperlipidemia, hypertension
- patients whose spot urine calcium level was over 30mg/dL.
Key Trial Info
Start Date :
May 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2022
Estimated Enrollment :
29 Patients enrolled
Trial Details
Trial ID
NCT05364567
Start Date
May 1 2018
End Date
May 1 2022
Last Update
May 6 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kangnam Sacred Heart Hospital
Seoul, South Korea